Biontech Se share price today

(BNTX)

Biontech Se share price is $113.08 & ₹9,609.09 as on 21 Dec 2024, 2.30 'hrs' IST

$113.08

▲

1.74

(1.56%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Biontech Se share price in Dollar and Rupees. Guide to invest in Biontech Se from India. Also see the sentimental analysis on Indian investors investing in Biontech Se. Get details on the Indian mutual funds that are investing in Biontech Se. Get Analyst recommendations and forecasts along with all the Biontech Se's financials.

Biontech Se share price movements

Today's Low: $110.30
Today's High: $115.17
$113.08
2.46%
Downside
Day's Volatility :4.23%
Upside
1.81%
52 Weeks Low: $76.53
52 Weeks High: $131.49
$113.08
32.32%
Downside
52 Weeks Volatility :41.8%
Upside
14.0%

Biontech Se Returns

Period	Biontech Se	Sector (Health Care)	Index (Russel 2000)
3 Months	0.03%	-11.1%	0.0%
6 Months	30.56%	-6.0%	0.0%
1 Year	7.97%	2.2%	0.0%
3 Years	-55.63%	-0.5%	-20.4%

Biontech Se Key Statistics

in dollars & INR

Previous Close	$111.34
Open	$110.76
Today's High	$115.17
Today's Low	$110.3
Market Capitalization	$26.7B
Today's Volume	$864.0K
52 Week High	$131.49
52 Week Low	$76.5301
Revenue TTM	$3.0B
EBITDA	$-274.5M
Earnings Per Share (EPS)	$-2.04
Profit Margin	-15.36%
Quarterly Earnings Growth YOY	0.23%
Return On Equity TTM	-2.4%

How to invest in Biontech Se from India?

It is very easy for Indian residents to invest directly in Biontech Se from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biontech Se stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biontech Se or BNTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biontech Se or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biontech Se shares which would translate to 0.008 fractional shares of Biontech Se as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Biontech Se, in just a few clicks!

Returns in Biontech Se for Indian investors in Rupees

Investment Value

₹1,00,000

Biontech Se investment value today

Current value as on today

₹1,10,169

Returns

₹10,169

(+10.17%)

Returns from Biontech Se Stock

₹7,973 (+7.97%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Biontech Se

31%

Period: Sep 23, 2024 to Dec 22, 2024. Change in 30 Days versus previous period

Search volume for Biontech Se on INDmoney from India has grown in the last 30 days as on Dec 23, 2024. 31% more investors are searching Biontech Se in the last 30 days versus the previous period.

Global Institutional Holdings in Biontech Se

Baillie Gifford & Co Limited.
3.47%
FMR Inc
2.63%
PRIMECAP Management Company
1.88%
Flossbach von Storch AG
1.82%
BlackRock Inc
0.79%
Temasek Holdings Ltd.
0.75%

Analyst Recommendation on Biontech Se

Buy

54%Buy

37%Hold

8%Sell

Based on 24 Wall street analysts offering stock ratings for Biontech Se(by analysts ranked 0 to 5 stars)

Based on 24 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biontech Se

What analysts predicted

Upside of 20.1%

Current:

$113.08

Target:

$135.81

Insights on Biontech Se

Price Movement
In the last 6 months, BNTX stock has moved up by 33.6%
Increasing Revenue
BioNTech SE has shown positive revenue growth over the last two quarters. Revenue increased from $128.7 million to $1.24 billion, with an average quarterly growth rate of 89.7%. This indicates strong performance and significant expansion in their financial results.
Increasing Net Profit
Biontech SE has shown a significant improvement in its net profit over the last two quarters. The company's net profit rose from a loss of $807.8 million to a profit of $198.1 million, reflecting an average increase of 507.8% per quarter.
BNTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 28.5% return, outperforming this stock by 21.1%
BNTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 31.0% return, outperforming this stock by 87.5%
Price to Sales
Currently, investors value Biontech SE at a Price-to-Sales Ratio of 9.0, meaning they are willing to pay $9.00 for every $1.00 of sales the company generates. In comparison, Alnylam Pharmaceuticals, Inc. has a higher Price-to-Sales Ratio of 14.9, indicating that investors are willing to pay more for each dollar of sales from that company.

Biontech Se Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$145.1M	↑ 107.11%
Net Income	$-54.6M	↓ 43.94%
Net Profit Margin	-37.64%	↑ 101.41%

	FY19	Y/Y Change
Revenue	$120.7M	↓ 14.88%
Net Income	$-199.1M	↑ 273.13%
Net Profit Margin	-165.0%	↓ 127.36%

	FY20	Y/Y Change
Revenue	$586.7M	↑ 344.17%
Net Income	$18.5M	↓ 108.48%
Net Profit Margin	3.15%	↑ 168.15%

	FY21	Y/Y Change
Revenue	$21.5B	↑ 3834.42%
Net Income	$11.6B	↑ 67613.82%
Net Profit Margin	54.24%	↑ 51.09%

	FY22	Y/Y Change
Revenue	$18.3B	↓ 8.78%
Net Income	$10.0B	↓ 8.34%
Net Profit Margin	54.5%	↑ 0.26%

	FY23	Y/Y Change
Revenue	$4.2B	↓ 77.94%
Net Income	$1.0B	↓ 90.14%
Net Profit Margin	24.36%	↓ 30.14%

	Q2 FY23	Q/Q Change
Revenue	$971.1M	↓ 29.89%
Net Income	$174.2M	↓ 68.02%
Net Profit Margin	17.94%	↓ 21.39%

	Q3 FY23	Q/Q Change
Revenue	$1.6B	↑ 65.2%
Net Income	$488.8M	↑ 185.12%
Net Profit Margin	30.96%	↑ 13.02%

	Q4 FY23	Q/Q Change
Revenue	$1.6B	↑ 0.0%
Net Income	$499.5M	↑ 0.0%
Net Profit Margin	30.96%	↑ 0.0%

	Q1 FY24	Q/Q Change
Revenue	$203.9M	↓ 87.32%
Net Income	$-342.5M	↓ 168.81%
Net Profit Margin	-167.96%	↓ 198.92%

	Q2 FY24	Q/Q Change
Revenue	$138.5M	↓ 31.4%
Net Income	$-869.2M	↑ 156.36%
Net Profit Margin	-627.66%	↓ 459.7%

	Q3 FY24	Q/Q Change
Revenue	$1.2B	↑ 867.21%
Net Income	$198.1M	↓ 124.52%
Net Profit Margin	15.91%	↑ 643.57%

	FY18	Y/Y Change
Profit	$-33.2M	↓ 12.23%

	FY19	Y/Y Change
Profit	$-150.3M	↑ 363.86%

	FY20	Y/Y Change
Profit	$-270.1M	↑ 64.18%

	FY21	Y/Y Change
Profit	$17.1B	↓ 6907.87%

	FY22	Y/Y Change
Profit	$13.5B	↓ 15.46%

	FY23	Y/Y Change
Profit	$3.5B	↓ 74.81%

	Q2 FY23	Q/Q Change
Profit	$255.6M	↓ 72.18%

	Q3 FY23	Q/Q Change
Profit	$1.4B	↑ 451.74%

	Q4 FY23	Q/Q Change
Profit	$1.4B	↑ 0.0%

	Q1 FY24	Q/Q Change
Profit	$139.7M	↓ 90.11%

	Q2 FY24	Q/Q Change
Profit	$74.1M	↓ 46.38%

	Q3 FY24	Q/Q Change
Profit	$1.1B	↑ 1447.02%

	FY18	Y/Y Change
Operating Cash Flow	$-66.2M	↑ 10.69%
Investing Cash Flow	$-75.6M	↑ 26.46%
Financing Cash Flow	$415.4M	↓ 22326.23%

	FY19	Y/Y Change
Operating Cash Flow	$-220.6M	↑ 241.25%
Investing Cash Flow	$-85.7M	↑ 16.05%
Financing Cash Flow	$425.9M	↑ 4.96%

	FY20	Y/Y Change
Operating Cash Flow	$-16.4M	↓ 93.21%
Investing Cash Flow	$-176.2M	↑ 87.83%
Financing Cash Flow	$1.1B	↑ 133.43%

	FY21	Y/Y Change
Operating Cash Flow	$1.0B	↓ 6703.09%
Investing Cash Flow	$-640.0M	↑ 290.82%
Financing Cash Flow	$106.5M	↓ 89.47%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$879.9M	↓ 219.75%
Investing Cash Flow	$-1.3B	↑ 0.0%
Financing Cash Flow	$-337.3M	↑ 6.76%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$908.4M	↑ 4.89%
Investing Cash Flow	$-1.3B	↑ 0.0%
Financing Cash Flow	$-13.8M	↓ 95.85%

Biontech Se Technicals Summary

Sell

Neutral

Buy

Biontech Se is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Biontech Se Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biontech Se	-0.04%	30.56%	7.97%	-55.63%	240.6%
Regeneron Pharmaceuticals, Inc.	-4.9%	-34.03%	-17.38%	10.57%	87.23%
Alnylam Pharmaceuticals, Inc.	0.22%	10.11%	28.37%	52.34%	108.41%
Vertex Pharmaceuticals Incorporated	-11.91%	-16.36%	-2.55%	78.68%	80.37%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biontech Se	Buy	$26.7B	240.6%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.23%	17.51	33.61%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.41%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.37%	32.84	-4.51%

Biontech Se Dividend announcements

Biontech Se Dividends June, 2022
In the quarter ending June,2022. Biontech Se has declared dividend of $2.11
Read More

About Biontech Se

everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/

Organization	Biontech Se
Employees	6133
CEO	Dr. Ugur Sahin M.D.
Industry	Health Technology

Management People of Biontech Se

Name	Title
Dr. Ugur Sahin M.D.	Co-Founder, CEO & Chair of the Management Board
Dr. Ozlem Tureci M.D.	Co-Founder, Chief Medical Officer & Member of Management Board
Mr. Jens H. Holstein	CFO & Member of Management Board
Dr. Sierk Poetting Ph.D.	MD, COO & Member of Management Board
Mr. Ryan Richardson	Chief Strategy Officer, MD & Member of Management Board
Dr. James Timothy Patrick Ryan Ph.D.	Chief Legal & Business Officer & Member of the Management Board
Mr. Sean Marett	Executive Officer
Ms. Lisa Birringer	Senior Vice President of Global Financial Reporting & Accounting
Mr. Zach Taylor	Senior Vice President of Corporate Development & Strategy
Dr. Katalin Kariko Ph.D.	Senior VP & External Consultant for RNA Protein Replacement Therapies

Important FAQs about investing in Biontech Se from India :

What is Biontech Se share price today?

Biontech Se share price today stands at $113.08, Open: $110.76 ; Previous Close: $111.34 ; High: $115.17 ; Low: $110.30 ; 52 Week High: $131.49 ; 52 Week Low: $76.53. The stock opens at $110.76, after a previous close of $111.34. The stock reached a daily high of $115.17 and a low of $110.30, with a 52-week high of $131.49 and a 52-week low of $76.53.

Can Indians buy Biontech Se shares?

Yes, Indians can invest in the Biontech Se (BNTX) from India.

With INDmoney, you can buy Biontech Se at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biontech Se at zero transaction cost.

How can I buy Biontech Se shares from India?

It is very easy to buy Biontech Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biontech Se be purchased?

Yes, you can buy fractional shares of Biontech Se with INDmoney app.

What are the documents required to start investing in Biontech Se stocks?

To start investing in Biontech Se, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.